Endofotonics
Medical Device
11-50 Employees
4.5 (Glassdoor)
Unclaimed
Page has not been claimed by the company yet.
About Endofotonics
Endofotonics is a medtech organisation dedicated to using its proprietary Raman spectroscopy platform technology to improve early cancer detection and hence reduce cancer burden in patients.
To find out more, visit us at www.endofotonics.com or email your enquiries to contact@endofotonics.com
Follow and like us on facebook.com/endofotonics
_
Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDxâ„¢ system, the world's first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate.
Endofotonics is currently ran by a lean team of highly skilled and specialized engineers and PhD executives, with knowledge ranging from optics to biomedical, and skills from academic research to industrial product development. Overseeing Endofotonics as a business, the company is supported by board of directors and engineering scientific board that comprises of founders and thought leaders in their own field.
Endofotonics raised S$12 million in Series B funding earlier this year. This funding will be used to support the commercialisation of the SPECTRA IMDx in Asia Pacific and beyond.
To find out more, visit us at www.endofotonics.com or email your enquiries to contact@endofotonics.com
Follow and like us on facebook.com/endofotonics
_
Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDxâ„¢ system, the world's first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate.
Endofotonics is currently ran by a lean team of highly skilled and specialized engineers and PhD executives, with knowledge ranging from optics to biomedical, and skills from academic research to industrial product development. Overseeing Endofotonics as a business, the company is supported by board of directors and engineering scientific board that comprises of founders and thought leaders in their own field.
Endofotonics raised S$12 million in Series B funding earlier this year. This funding will be used to support the commercialisation of the SPECTRA IMDx in Asia Pacific and beyond.
Endofotonics Reviews
ADD A REVIEWEndofotonics Careers and Jobs (0)
There are no active jobs right now, but don't let it stop you!
Explore other jobsEndofotonics Culture
Endofotonics has not added their culture yet. Add them for FREE now!
Endofotonics Employee Benefits
Endofotonics has not added their benefits yet. Add them for FREE now!
Endofotonics Insights
Team Trend
Team Breakdown
Company
Frequently Asked Questions about Endofotonics
Endofotonics is a medtech organisation dedicated to using its proprietary Raman spectroscopy platform technology to improve early cancer detection and hence reduce cancer burden in patients.
To find out more, visit us at www.endofotonics.com or email your enquiries to contact@endofotonics.com
Follow and like us on facebook.com/endofotonics
_
Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDxâ„¢ system, the world's first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate.
Endofotonics is currently ran by a lean team of highly skilled and specialized engineers and PhD executives, with knowledge ranging from optics to biomedical, and skills from academic research to industrial product development. Overseeing Endofotonics as a business, the company is supported by board of directors and engineering scientific board that comprises of founders and thought leaders in their own field.
Endofotonics raised S$12 million in Series B funding earlier this year. This funding will be used to support the commercialisation of the SPECTRA IMDx in Asia Pacific and beyond.
To find out more, visit us at www.endofotonics.com or email your enquiries to contact@endofotonics.com
Follow and like us on facebook.com/endofotonics
_
Founded in 2013, the company is headquartered in Singapore and has a subsidiary in Shanghai, China. Endofotonics developed the SPECTRA IMDxâ„¢ system, the world's first real-time in-vivo Raman spectroscopy platform, that improves early gastric cancer detection rate.
Endofotonics is currently ran by a lean team of highly skilled and specialized engineers and PhD executives, with knowledge ranging from optics to biomedical, and skills from academic research to industrial product development. Overseeing Endofotonics as a business, the company is supported by board of directors and engineering scientific board that comprises of founders and thought leaders in their own field.
Endofotonics raised S$12 million in Series B funding earlier this year. This funding will be used to support the commercialisation of the SPECTRA IMDx in Asia Pacific and beyond.
There are no Endofotonics jobs right now, but you can explore similar jobs.
According to anonymously submitted Glassdoor reviews, Endofotonics has an overall rating of 4.5 out of 5 based on reviews left by employees. Find out more about salaries and benefits at Endofotonics.
